Martin M. McGlynn
Directeur Général chez StemCells California, Inc.
Profil
Martin M.
McGlynn currently works at StemCells California, Inc., as President & Chief Executive Officer from 2001 and Regenerative Medicine Foundation, as Director from 2016.
Mr. McGlynn also formerly worked at StemCells, Inc., as Chief Executive Officer & Director from 2015 to 2016, Inflabloc Pharmaceuticals, Inc., as President & Chief Executive Officer, Pharmaceutical Manufacturers Association of Canada, as Director, Confederation of Irish Industry, as Director, Alliance for Regenerative Medicine, as Director, Abbott International LLC, as Vice President, Abbott Ireland Ltd., as General Manager, Abbott Canada, as President & General Manager, and Anaquest, Inc., as President.
Mr. McGlynn received his undergraduate degree from University College Dublin.
Postes actifs de Martin M. McGlynn
| Sociétés | Poste | Début |
|---|---|---|
| StemCells California, Inc. | Directeur Général | 15/01/2001 |
Regenerative Medicine Foundation
 Regenerative Medicine Foundation Medical SpecialtiesHealth Technology The Regenerative Medicine Foundation is a non-profit organization that aims to accelerate the development of regenerative medicine to improve health and deliver cures. The non-profit company is based in Winston-Salem, NC. The foundation fosters strategic collaborations to achieve its mission and produces its flagship event, the World Stem Cell Summit. Additionally, the foundation honors leaders in the field through the Stem Cell and Regenerative Medicine Action Awards and promotes educational initiatives. | Directeur/Membre du Conseil | 07/09/2016 |
Anciens postes connus de Martin M. McGlynn
| Sociétés | Poste | Fin |
|---|---|---|
StemCells, Inc.
 StemCells, Inc. BiotechnologyHealth Technology StemCells, Inc. engages in the research, development and commercialization of stem cell therapeutics and related tools and technologies for academia and industry. The company is focused on developing and commercializing stem and progenitor cells as the basis for novel therapeutics and therapies; and cells and related tools and technologies to enable stem cell-based research and drug discovery and development. StemCells research and development efforts are focused on identifying and developing stem and progenitor cells as potential therapeutic agents. The company was founded by David J. Anderson and Fred H. Gage in August 1988 and is headquartered in Newark, CA. | Directeur Général | 17/01/2016 |
Alliance for Regenerative Medicine
 Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field. | Directeur/Membre du Conseil | - |
Inflabloc Pharmaceuticals, Inc.
 Inflabloc Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Inflabloc Pharmaceuticals, Inc. engages in the research and development of pharmaceutical treatments. It develops products for the treatment of gastrointestinal disorders and inflammatory diseases. The company was founded in 1991 and is headquartered in Salt Lake City, UT. | President | - |
| Confederation of Irish Industry | Directeur/Membre du Conseil | - |
| Anaquest, Inc. | President | - |
Formation de Martin M. McGlynn
| University College Dublin | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
StemCells, Inc.
StemCells, Inc. BiotechnologyHealth Technology StemCells, Inc. engages in the research, development and commercialization of stem cell therapeutics and related tools and technologies for academia and industry. The company is focused on developing and commercializing stem and progenitor cells as the basis for novel therapeutics and therapies; and cells and related tools and technologies to enable stem cell-based research and drug discovery and development. StemCells research and development efforts are focused on identifying and developing stem and progenitor cells as potential therapeutic agents. The company was founded by David J. Anderson and Fred H. Gage in August 1988 and is headquartered in Newark, CA. | Health Technology |
Inflabloc Pharmaceuticals, Inc.
Inflabloc Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Inflabloc Pharmaceuticals, Inc. engages in the research and development of pharmaceutical treatments. It develops products for the treatment of gastrointestinal disorders and inflammatory diseases. The company was founded in 1991 and is headquartered in Salt Lake City, UT. | Commercial Services |
| StemCells California, Inc. | |
| Abbott International LLC | |
| Pharmaceutical Manufacturers Association of Canada | |
Abbott Ireland Ltd.
 Abbott Ireland Ltd. Medical SpecialtiesHealth Technology Part of Abbott Laboratories, Abbott Ireland Ltd. is an Irish company that helps people live healthier lives through their life-changing technology. The company is based in Dublin, Ireland. The company's technology focuses on keeping the heart healthy, nourishing the body at every stage of life, improving movement, and providing information, medicines, and breakthroughs to manage health. | Health Technology |
| Abbott Canada | |
| Anaquest, Inc. | |
| Confederation of Irish Industry | |
Alliance for Regenerative Medicine
Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field. | Health Services |
Regenerative Medicine Foundation
Regenerative Medicine Foundation Medical SpecialtiesHealth Technology The Regenerative Medicine Foundation is a non-profit organization that aims to accelerate the development of regenerative medicine to improve health and deliver cures. The non-profit company is based in Winston-Salem, NC. The foundation fosters strategic collaborations to achieve its mission and produces its flagship event, the World Stem Cell Summit. Additionally, the foundation honors leaders in the field through the Stem Cell and Regenerative Medicine Action Awards and promotes educational initiatives. | Health Technology |